Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia

Lancet. 2022 May 7;399(10337):1755-1757. doi: 10.1016/S0140-6736(22)00624-9. Epub 2022 Apr 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Topical
  • Aminoquinolines / therapeutic use
  • Antineoplastic Agents* / therapeutic use
  • Carcinoma in Situ* / drug therapy
  • Female
  • Humans
  • Imiquimod / therapeutic use
  • Vulvar Neoplasms* / drug therapy

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod